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An	   inflammatory	   infiltrate,	   consisting	  mainly	  of	   lymphoid	   cells,	  plays	  a	  key-­‐role	   in	   the	  prognosis	  of	  
melanoma	   as	   well	   as	   in	   immunotherapy	   efficiency.	   The	   inflammatory	   tumor	  microenvironment	   is	  
notably	  composed	  of	  T	  helper	  17	  (Th17)	  cells,	  a	  subtype	  of	  CD4+	  T	  lymphocytes.	  Clinical	  data	  on	  their	  
involvement	  in	  melanoma	  are	  lacking.	  In	  this	  work,	  we	  characterized	  the	  Th17	  infiltration	  related	  to	  
different	  stages	  of	  melanoma.	  
Immunohistochemistry	   on	   human	   cutaneous	   biopsies	   using	   an	   anti-­‐interleukin	   (IL)-­‐17	   antibody	  
allowed	   the	   location	  of	   IL-­‐17+	  cells	   closed	   to	  vessels,	   in	   the	  papillary	  dermis	  and	   in	   the	  uppermost	  
part	   of	   the	   reticular	   dermis	   whatever	   the	   melanoma	   stage.	   Furthermore,	   a	   preliminary	   semi	  
quantitative	   analysis	   based	   on	   the	   scoring	   of	   cell	   density	   within	   “hotspots”	   on	   patient	   biopsies	  
highlights	   an	   increase	   of	   IL-­‐17+	   cells	   according	   to	   the	   stage	   of	  melanoma.	   This	   increase	   reaches	   a	  
significant	   level	   (p<0.05)	  between	  advanced	  stages	  (n=11)	  of	  melanoma	  and	  nevi	   (used	  as	  negative	  
control)	  (n=19).	  	  
In	   order	   to	   characterize	   cells	   producing	   IL-­‐17,	   double	   immunolabellings	   IL-­‐17/CD4	   and	   IL-­‐17/CD8	  
using	  confocal	  microscopy	  have	  been	  performed.	  Indeed,	  other	  cells	  than	  CD4+	  like	  γδ	  T	  cells,	  CD8+	  T	  
cells	   and	  macrophages	   could	   express	   this	   cytokine.	  Our	   results	   show	   that	  most	   of	   IL-­‐17+	   cells	   are	  
Th17	  cells	  and	  express	  CD4,	  only	  a	  small	  proportion	  of	  IL-­‐17+	  cells	  express	  the	  CD8.	  	  
In	  conclusion,	  our	  results	  show	  a	  more	  important	  infiltration	  of	  IL-­‐17+	  cells,	  mainly	  Th17	  cells,	  in	  the	  
microenvironment	  of	  advanced	  stage	  melanoma.	  These	  data	  suggest	  that	  Th17	  cells	  could	  be	  a	  good	  
factor	   which	   determines	   the	   outcome	   of	   the	   disease	   and	   the	   orientation	   of	   immunotherapy.	  
Therefore,	  the	  study	  of	  their	  controversial	  protumor	  or	  antitumor	  function	  is	  planned	  by	  our	  team.	  	  
